Skip to main content
4DMEDICAL LIMITED logo

4DMEDICAL LIMITED — Investor Relations & Filings

Ticker · 4DX ISIN · AU0000095416 LEI · 9845000A8F12A6A6FD75 ASX Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 546 across all filing types
Latest filing 2025-12-30 Regulatory Filings
Country AU Australia
Listing ASX 4DX

About 4DMEDICAL LIMITED

https://4dmedical.com/

4DMedical Limited develops non-invasive respiratory imaging solutions centered on its proprietary XV Technology. This platform utilizes advanced algorithms to transform standard X-ray sequences into four-dimensional quantitative data, visualizing regional lung function in motion. The flagship XV Lung Ventilation Analysis Software (XV LVAS) provides clinicians with detailed maps of airflow distribution throughout the respiratory cycle, facilitating the early detection and monitoring of chronic conditions such as COPD, asthma, and interstitial lung disease. By providing objective, high-resolution insights into lung ventilation without the limitations of traditional pulmonary function tests, the company's cloud-based diagnostic tools aim to improve clinical workflows and patient management. The integration of artificial intelligence further enhances its capability to deliver precise, automated lung tissue analysis.

Recent filings

Filing Released Lang Actions
Appendix 2A 20 pages 499.0KB
Regulatory Filings Classification · 95% confidence The document is titled 'Appendix 2A Application for quotation of securities' and is structured as a form for applying for the quotation of securities on the ASX (Australian Securities Exchange). It includes detailed information about the entity, the securities to be quoted, dates of issue, and types of securities involved, such as options exercised or convertible securities converted. The document is a regulatory form used to notify the exchange about new securities being quoted, not a financial report or announcement of financial results. It is not an announcement of voting results, nor a management or board change, nor a report on earnings or capital structure changes. It is a formal regulatory filing related to securities quotation under ASX Listing Rules, which fits best under the category of Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2025-12-30 English
Appendix 2A 20 pages 499.1KB
Regulatory Filings Classification · 95% confidence The document is titled 'Appendix 2A Application for quotation of securities' and is structured as a form for applying for the quotation of securities on the ASX (Australian Securities Exchange). It includes detailed information about the entity, the securities to be quoted, dates of issue, and the nature of the securities (e.g., options exercised or convertible securities converted). The document is a regulatory form used to notify the exchange about new securities being quoted, not a financial report or announcement of financial results. It is not an announcement of voting results, nor a management or board change, nor a report on earnings or capital structure updates. It is a formal application for quotation of securities, which fits the category of a regulatory filing. Given the detailed nature and regulatory context, the best classification is Regulatory Filings (RNS). The document length and content confirm it is not a brief announcement or a report publication announcement but a substantive regulatory filing form.
2025-12-28 English
Application for quotation of securities - 4DX 6 pages 18.4KB
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Appendix 2A - Application for quotation of securities' and details the application for quotation of securities on the ASX. It includes information about securities issued due to options being exercised or convertible securities being converted, the number of securities to be quoted, issue dates, and issued capital following quotation. This is a formal announcement related to the issuance and quotation of new securities, which aligns with announcements about new share issues or capital changes. The document is about the application for quotation of securities rather than a financial report or earnings release. Therefore, it fits the category of Share Issue/Capital Change (SHA). The document length is 6015 characters, which is sufficient to contain substantive details about the share issue.
2025-12-23 English
Cleveland Clinic adopts CTVQ 2 pages 240.5KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 19 December 2025, describing a commercial arrangement between 4DMedical and Cleveland Clinic for the clinical use of CT:VQ™ technology. It highlights the adoption of the technology by a major healthcare institution and discusses the company's commercialisation strategy. There are no financial statements, regulatory filings, or detailed financial data presented. The document is a corporate announcement about a commercial partnership and product adoption, not a financial report, earnings release, or regulatory filing. It is not a report publication announcement since it does not mention the release or availability of a report. Therefore, the document best fits the category of a Regulatory Filing (RNS) as a general corporate announcement that does not fit other specific categories.
2025-12-18 English
Application for quotation of securities - 4DX 9 pages 25.7KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 2A - Application for quotation of securities' and contains detailed information about securities issued, transferred, or re-classified due to options being exercised or convertible securities being converted. It includes specifics such as the number of securities, issue dates, consideration for securities, and the resulting issued capital. The document is a formal application to the ASX (Australian Securities Exchange) for the quotation of these securities. This type of filing corresponds to announcements regarding new share issues or capital changes. It is not a financial report, earnings release, or management discussion, but rather a regulatory announcement about capital changes. Therefore, the appropriate classification is 'Share Issue/Capital Change' (SHA). The document length and detail confirm it is not a brief announcement or a report publication notice, but a substantive filing about capital changes.
2025-12-18 English
Application for quotation of securities - 4DX 7 pages 21.0KB
Share Issue/Capital Change Classification · 100% confidence The document is an Appendix 2A form, which is a standard ASX (Australian Securities Exchange) form used for the application for quotation of securities. It details the issuance and quotation of securities under an employee incentive scheme, including the number of securities, issue date, and related information. It is not a financial report, earnings release, or management discussion, but rather a regulatory announcement about new securities being quoted on the exchange. This fits the category of Share Issue/Capital Change (SHA), as it announces new securities being issued and quoted.
2025-12-18 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.